Urinary fetuin-A is associated with chronic histological damage and adverse clinical outcomes across a variety of biopsy-proven kidney diseases [16], and an increased excretion of uPTM3-FetA in patients with CKD, regardless of the diabetes diagnosis, was found [17]. This evidence concerns the gene AHSG and chronic kidney disease.